Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
Research ArticleOriginal Article

Three-dimensional collagen-based scaffold model to study the microenvironment and drug-resistance mechanisms of oropharyngeal squamous cell carcinomas

Giacomo Miserocchi, Claudia Cocchi, Alessandro De Vita, Chiara Liverani, Chiara Spadazzi, Sebastiano Calpona, Giandomenico Di Menna, Massimo Bassi, Giuseppe Meccariello, Giovanni De Luca, Angelo Campobassi, Maria Maddalena Tumedei, Alberto Bongiovanni, Valentina Fausti, Franco Cotelli, Toni Ibrahim and Laura Mercatali
Cancer Biology & Medicine May 2021, 18 (2) 502-516; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0482
Giacomo Miserocchi
1Osteoncology and Rare Tumors Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola 47014, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudia Cocchi
1Osteoncology and Rare Tumors Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola 47014, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alessandro De Vita
1Osteoncology and Rare Tumors Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola 47014, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alessandro De Vita
  • For correspondence: [email protected]
Chiara Liverani
1Osteoncology and Rare Tumors Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola 47014, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chiara Spadazzi
1Osteoncology and Rare Tumors Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola 47014, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sebastiano Calpona
1Osteoncology and Rare Tumors Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola 47014, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giandomenico Di Menna
1Osteoncology and Rare Tumors Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola 47014, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Massimo Bassi
2Maxillofacial Surgery Unit, Bufalini Hospital, Cesena 47521, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giuseppe Meccariello
3Department of Head-Neck Surgery, Otolaryngology, Head-Neck and Oral Surgery Unit, Morgagni Pierantoni Hospital, Forlì 47121, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giovanni De Luca
4Pathology Unit, “Bufalini” Hospital, AUSL Romagna, Cesena 47521, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angelo Campobassi
2Maxillofacial Surgery Unit, Bufalini Hospital, Cesena 47521, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Maddalena Tumedei
5Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola 47014, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alberto Bongiovanni
1Osteoncology and Rare Tumors Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola 47014, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valentina Fausti
1Osteoncology and Rare Tumors Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola 47014, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Franco Cotelli
6Department of Biosciences, Università degli Studi di Milano, Milan 20133, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toni Ibrahim
1Osteoncology and Rare Tumors Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola 47014, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Mercatali
1Osteoncology and Rare Tumors Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola 47014, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Supplementary Materials
  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    Characterization of the 3D oropharyngeal squamous cell carcinoma culture model. (A) Fold changes in percentage of cell proliferation (relative to hour 0) of UM-SCC6 and UPCI:SCC090 in monolayer (2D) and in scaffolds (3D) after 24 h, 72 h, and 5 days. (B) Whole images of histological sections of scaffold cultured with UM-SCC6 and UPCI:SCC090 on days 1 and 5. Cells are stained with DAPI (blue) and green is the collagen scaffold autofluorescence. Scale bars: 1 mm. (C, D) Cell percentage in the core and at the edge of the scaffold area. Data represent mean ± standard deviation. *P < 0.05, 2-tailed Student’s t-test. (E) Images of H&E-stained histological sections and confocal images of UM-SCC6 and UPCI:SCC090 scaffold cultures. From above: H&E images at 4× magnification (scale bars: 100 µm) and 20× magnification (scale bars: 50 µm); confocal images of sections stained with phalloidin in red and DAPI in blue (scale bar: 20 µm). (F, G) CDH1, VIM, and SNAIL relative mRNA expression in UM-SCC6 and UPCI:SCC090 within the scaffold vs. 2D cultures after 24, 48, and 72 h. Data represent mean ± standard deviation. *P < 0.05, 2-tailed Student’s t-test. 3D, 3-dimensional; 2D, 2-dimensional; H&E, hematoxylin and eosin; DAPI, 4′,6-diamidino-2-phenylindole.

  • Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2

    Cells cultured in the scaffold interact with collagen fiber network and display higher cell migration inside the vessels of zebrafish embryos. (A, B) UM-SCC6 and UPCI:SCC090 relative expression levels of MMP2, MMP9, and LOX in 3D vs. 2D cultures after 24 h, 48 h, and 72 h. Data represent mean ± standard deviation. *P < 0.05, 2-tailed Student’s t-test. (C, D) Representative pictures of Tg(fli1:EGFP) embryos injected with UM-SCC6 and UPCI:SCC090 recovered from 2D and 3D cultures and labeled with a red fluorescent dye (CM-Dil). The images show the whole embryo body and tail region details at 24 hpi. The white asterisks show single or small cell clusters. (E, F) Percentage of embryos showing distant micrometastases. Data represent mean ± standard error. *P < 0.05, 2-tailed Student’s t-test. 3D, 3-dimensional; 2D, 2-dimensional.

  • Figure 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3

    3D microenvironment induces hypoxic and glycolytic adaptation by oropharyngeal squamous cell carcinoma cells. (A) Representative images of HIF-1α-stained cytospinned cells and histological sections of 2D and 3D cultures (scale bar: 50 µm). (B, C) Percentage of HIF-1α-positive cells in 2D and 3D cultures of UM-SCC6 and UPCI:SCC090 after 24, 48, and 72 h. Data represent mean ± standard deviation. *P < 0.05, 2-tailed Student’s t-test. (D) GAPDH mRNA expression levels in 3D vs. 2D cultures after 24, 48, and 72 h. Data represent mean ± standard deviation. *P < 0.05, 2-tailed Student’s t-test. (E) Representative images of GLUT-1-stained cytospinned cells and histological sections of 2D and 3D cultures (scale bar: 50 µm). 3D, 3-dimensional; HIF-1α, hypoxia-inducible factor 1α; 2D, 2-dimensional; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; GLUT-1, glucose transporter.

  • Figure 4
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4

    3D cultured cells acquire drug-resistance mechanisms. (A, B) Cytotoxicity analysis of UM-SCC6 and UPCI:SCC090 cell lines treated with cisplatin, 5-fluorouracil, cetuximab, and gemcitabine. Differences between 2D and 3D cultures were assessed by a 2-tailed Student’s t-test and accepted as significant (*) at P < 0.05. (C, D) NT5E, FOXM1, FLT1, and ABCA3 gene expression analysis in 3D vs. 2D cultures after 24, 48, and 72 h. Data represent mean ± standard deviation. *P < 0.05, 2-tailed Student’s t-test. 3D, 3-dimensional; CIS, cisplatin; 5-FU, 5-fluorouracil; CETU, cetuximab; GEM, gemcitabine; 2D, 2-dimensional.

  • Figure 5
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5

    Drug-resistance mechanisms are also conserved in HNC patient-derived primary cultures. (A, B) VIM, CDH1, CXCR4, TP53, TGFβ, MMP2, and MMP9 gene expression analysis in patient tumor tissue (HN2 K and HN14 K) vs. healthy tissue (HN2 H and HN14 H). Data represent mean ± standard deviation. *P < 0.05, 2-tailed Student’s t-test. (C, D) Images of H&E-stained histological sections of HN2 and HN14 3D primary cultures. From left: H&E images at 10× magnification (scale bars: 100 µm) and 20× magnification (scale bars: 50 µm). (E, F) Cytotoxic analysis of HN2 and HN14 primary cultures. 2D and 3D cultures were treated with CIS, 5-FU, CETU, and GEM. Differences between 2D and 3D cultures were assessed by a 2-tailed Student’s t-test and accepted as significant (*) at P < 0.05. HNC, head and neck carcinoma; H&E, hematoxylin and eosin; 3D, 3-dimensional; 2D, 2-dimensional; CIS, cisplatin; 5-FU, 5-fluorouracil; CETU, cetuximab; GEM, gemcitabine.

Tables

  • Figures
  • Supplementary Materials
    • View popup
    Table 1

    Patient characteristics

    PatientGenderAge (years) at surgerySiteSize (cm)Histological subtypeTNM staging
    HN2M78Oral cavity (gingiva)8 × 4.5 × 1.1SCCT4aN2bM0
    HN14F61Oral cavity (gingiva and mandible)8 × 7 × 5SCCT4aN0M0

    M, male; F, female; SCC, squamous cell carcinoma.

    Supplementary Materials

    • Figures
    • Tables
    • [cbm-18-502-s001.pdf]
    PreviousNext
    Back to top

    In this issue

    Cancer Biology and Medicine: 18 (2)
    Cancer Biology & Medicine
    Vol. 18, Issue 2
    1 May 2021
    • Table of Contents
    • Index by author
    Print
    Download PDF
    Email Article

    Thank you for your interest in spreading the word on Cancer Biology & Medicine.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Three-dimensional collagen-based scaffold model to study the microenvironment and drug-resistance mechanisms of oropharyngeal squamous cell carcinomas
    (Your Name) has sent you a message from Cancer Biology & Medicine
    (Your Name) thought you would like to see the Cancer Biology & Medicine web site.
    Citation Tools
    Three-dimensional collagen-based scaffold model to study the microenvironment and drug-resistance mechanisms of oropharyngeal squamous cell carcinomas
    Giacomo Miserocchi, Claudia Cocchi, Alessandro De Vita, Chiara Liverani, Chiara Spadazzi, Sebastiano Calpona, Giandomenico Di Menna, Massimo Bassi, Giuseppe Meccariello, Giovanni De Luca, Angelo Campobassi, Maria Maddalena Tumedei, Alberto Bongiovanni, Valentina Fausti, Franco Cotelli, Toni Ibrahim, Laura Mercatali
    Cancer Biology & Medicine May 2021, 18 (2) 502-516; DOI: 10.20892/j.issn.2095-3941.2020.0482

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Share
    Three-dimensional collagen-based scaffold model to study the microenvironment and drug-resistance mechanisms of oropharyngeal squamous cell carcinomas
    Giacomo Miserocchi, Claudia Cocchi, Alessandro De Vita, Chiara Liverani, Chiara Spadazzi, Sebastiano Calpona, Giandomenico Di Menna, Massimo Bassi, Giuseppe Meccariello, Giovanni De Luca, Angelo Campobassi, Maria Maddalena Tumedei, Alberto Bongiovanni, Valentina Fausti, Franco Cotelli, Toni Ibrahim, Laura Mercatali
    Cancer Biology & Medicine May 2021, 18 (2) 502-516; DOI: 10.20892/j.issn.2095-3941.2020.0482
    Twitter logo Facebook logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • Introduction
      • Materials and methods
      • Results
      • Discussion
      • Conclusions
      • Supporting Information
      • Acknowledgements
      • Footnotes
      • References
    • Figures & Data
    • Info & Metrics
    • References
    • PDF

    Related Articles

    • No related articles found.
    • Google Scholar

    Cited By...

    • Smart drug delivery systems to overcome drug resistance in cancer immunotherapy
    • Smart drug delivery systems to overcome drug resistance in cancer immunotherapy
    • Google Scholar

    More in this TOC Section

    • High-precision immune-related plasma proteomics profiling predicts response to immunotherapy in patients with triple-negative breast cancer
    • Beyond gold: the chemoenhancing mechanism and therapeutic potential of auranofin in melanoma
    • Plasma L-aspartic acid predicts the risk of gastric cancer and modifies the primary prevention effect: a multistage metabolomic profiling and Mendelian randomization study
    Show more Original Article

    Similar Articles

    Keywords

    • Oropharyngeal squamous cell carcinoma
    • collagen
    • biomimetic scaffold
    • zebrafish
    • drug-resistance
    • primary culture

    Navigate

    • Home
    • Current Issue

    More Information

    • About CBM
    • About CACA
    • About TMUCIH
    • Editorial Board
    • Subscription

    For Authors

    • Instructions for authors
    • Journal Policies
    • Submit a Manuscript

    Journal Services

    • Email Alerts
    • Facebook
    • RSS Feeds
    • Twitter

     

    © 2025 Cancer Biology & Medicine

    Powered by HighWire